Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
23
Frequently Asked Questions
What is Market Cap of Citius Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Citius Pharmaceuticals Inc market cap is $20.24M.
What is the 52-week high for Citius Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Citius Pharmaceuticals Inc 52 week high is $13.52 as of September 25, 2025.
What is the 52-week low for Citius Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Citius Pharmaceuticals Inc 52 week low is $0.65 as of September 25, 2025.
What is Citius Pharmaceuticals Inc stock price today?
Citius Pharmaceuticals Inc stock price today is $1.15.
What was Citius Pharmaceuticals Inc stock price yesterday?
Citius Pharmaceuticals Inc stock price yesterday was $1.19.
What is the PE ratio of Citius Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Citius Pharmaceuticals Inc’s P/E ratio is -0.24.
What is the Price-to-Book ratio of Citius Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Citius Pharmaceuticals Inc P/B ratio is 0.2648.
What is the 50-day moving average of Citius Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Citius Pharmaceuticals Inc 50-day moving average is $1.32.
How many employess does Citius Pharmaceuticals Inc has?
CTXR Citius Pharmaceuticals Inc